ID

14392

Descripción

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00529529

Link

https://clinicaltrials.gov/show/NCT00529529

Palabras clave

Versiones (1)
  1. 13/4/16 13/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

13 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00529529

Inglés

Eligibility Asthma NCT00529529

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00529529
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female patients aged ≥ 12 years (or ≥ 18 years depending upon regulatory and/or institutional review board/independent ethics committee/research ethics board [irb/iec/reb] approval) who have signed an informed consent form.
Descripción

age and informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
2. patients with moderate to severe persistent asthma, diagnosed according to the global initiative for asthma (gina) guidelines (updated 2006) and who additionally meet the following criteria:
Descripción

moderate to severe persistent asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1960047
UMLS CUI [2]
C1960048
patients who have used treatment with a bronchodilator, either regularly or on-demand, and who had used a daily dose of at least 100 μg beclomethasone dipropionate (or equivalent) for at least 1 month prior to screening.
Descripción

bronchodilator and beclomethasone dipropionate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006280
UMLS CUI [2,1]
C0004906
UMLS CUI [2,2]
C2348070
UMLS CUI [3]
C0040223
patients whose forced expiratory volume in 1 second (fev1) is ≥ 50% of the predicted normal value.
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
patients with documented (in the previous 6 months) or who demonstrate (prior to randomization) a ≥ 12% and at least 200 ml increase in fev1, after inhaling 200
Descripción

fev1 post-bronchodilator

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599594
μg salbutamol.
Descripción

salbutamol

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001927
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnant or nursing (lactating) women and women of child-bearing potential unless they meet pre-specified definitions of post-menopausal or are using pre-specified acceptable methods of contraception.
Descripción

pregnant or nursing (lactating) women and women of child-bearing potential unless they meet pre-specified definitions of post-menopausal or are using pre-specified acceptable methods of contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C3831118
UMLS CUI [4]
C0700589
UMLS CUI [5]
C0232970
2. patients who have used tobacco products within the 12 month period prior to screening, or who have a smoking history of greater than 10 pack years.
Descripción

smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
3. patients who suffer from chronic obstructive pulmonary disease (copd) as diagnosed by the global initiative for chronic obstructive lung disease (gold) guidelines (2006).
Descripción

copd

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024117
4. patients who have had emergency room treatment for an acute asthma attack in the 6 weeks prior to screening or who have been hospitalized for an acute asthma attack in the 6 months prior to screening, or at any time between screening and week 1.
Descripción

emergency room or hospitalization for asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0583237
UMLS CUI [1,2]
C0347950
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0347950
5. patients with diabetes type i or those with uncontrolled diabetes type ii including patients with a history of blood glucose levels consistently outside the normal range or glycosylated hemoglobin (hba1c) > 8.0% measured at screening.
Descripción

diabetes mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0202042
UMLS CUI [3]
C0019018
6. patients who, in the judgment of the investigator or the responsible novartis personnel, have a clinically significant condition or a clinically relevant laboratory abnormality that might compromise patient safety or compliance, interfere with evaluation, or preclude completion of the study.
Descripción

comorbidity limiting study protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
7. patients with a history of long qt syndrome, or whose qtc interval (bazett's formula) is prolonged to > 450 ms (males) or > 470 ms (females).
Descripción

long qt syndrome or whose qtc interval (bazett's formula) is prolonged

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023976
UMLS CUI [2]
C0151878
8. certain medications for asthma and allied conditions such as long-acting bronchodilators must not be used prior to screening and for a pre-specified minimum washout period.
Descripción

asthma medication

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C0040223
other protocol-defined inclusion/exclusion criteria applied to the study.
Descripción

criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242801
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00529529

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00529529
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age and informed consent
Item
1. male and female patients aged ≥ 12 years (or ≥ 18 years depending upon regulatory and/or institutional review board/independent ethics committee/research ethics board [irb/iec/reb] approval) who have signed an informed consent form.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
moderate to severe persistent asthma
Item
2. patients with moderate to severe persistent asthma, diagnosed according to the global initiative for asthma (gina) guidelines (updated 2006) and who additionally meet the following criteria:
boolean
C1960047 (UMLS CUI [1])
C1960048 (UMLS CUI [2])
bronchodilator and beclomethasone dipropionate
Item
patients who have used treatment with a bronchodilator, either regularly or on-demand, and who had used a daily dose of at least 100 μg beclomethasone dipropionate (or equivalent) for at least 1 month prior to screening.
boolean
C0006280 (UMLS CUI [1])
C0004906 (UMLS CUI [2,1])
C2348070 (UMLS CUI [2,2])
C0040223 (UMLS CUI [3])
fev1
Item
patients whose forced expiratory volume in 1 second (fev1) is ≥ 50% of the predicted normal value.
boolean
C0748133 (UMLS CUI [1])
fev1 post-bronchodilator
Item
patients with documented (in the previous 6 months) or who demonstrate (prior to randomization) a ≥ 12% and at least 200 ml increase in fev1, after inhaling 200
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
salbutamol
Item
μg salbutamol.
boolean
C0001927 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or nursing (lactating) women and women of child-bearing potential unless they meet pre-specified definitions of post-menopausal or are using pre-specified acceptable methods of contraception
Item
1. pregnant or nursing (lactating) women and women of child-bearing potential unless they meet pre-specified definitions of post-menopausal or are using pre-specified acceptable methods of contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
C0232970 (UMLS CUI [5])
smoking history
Item
2. patients who have used tobacco products within the 12 month period prior to screening, or who have a smoking history of greater than 10 pack years.
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
copd
Item
3. patients who suffer from chronic obstructive pulmonary disease (copd) as diagnosed by the global initiative for chronic obstructive lung disease (gold) guidelines (2006).
boolean
C0024117 (UMLS CUI [1])
emergency room or hospitalization for asthma
Item
4. patients who have had emergency room treatment for an acute asthma attack in the 6 weeks prior to screening or who have been hospitalized for an acute asthma attack in the 6 months prior to screening, or at any time between screening and week 1.
boolean
C0583237 (UMLS CUI [1,1])
C0347950 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2,1])
C0347950 (UMLS CUI [2,2])
diabetes mellitus
Item
5. patients with diabetes type i or those with uncontrolled diabetes type ii including patients with a history of blood glucose levels consistently outside the normal range or glycosylated hemoglobin (hba1c) > 8.0% measured at screening.
boolean
C0011849 (UMLS CUI [1])
C0202042 (UMLS CUI [2])
C0019018 (UMLS CUI [3])
comorbidity limiting study protocol
Item
6. patients who, in the judgment of the investigator or the responsible novartis personnel, have a clinically significant condition or a clinically relevant laboratory abnormality that might compromise patient safety or compliance, interfere with evaluation, or preclude completion of the study.
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
long qt syndrome or whose qtc interval (bazett's formula) is prolonged
Item
7. patients with a history of long qt syndrome, or whose qtc interval (bazett's formula) is prolonged to > 450 ms (males) or > 470 ms (females).
boolean
C0023976 (UMLS CUI [1])
C0151878 (UMLS CUI [2])
asthma medication
Item
8. certain medications for asthma and allied conditions such as long-acting bronchodilators must not be used prior to screening and for a pre-specified minimum washout period.
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
criteria
Item
other protocol-defined inclusion/exclusion criteria applied to the study.
boolean
C0242801 (UMLS CUI [1])
Volver a la parte superior de la página 

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial